These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35981819)

  • 41. Efficient targeted mutation of genomic essential genes in yeast Saccharomyces cerevisiae.
    Yang S; Cao X; Yu W; Li S; Zhou YJ
    Appl Microbiol Biotechnol; 2020 Apr; 104(7):3037-3047. PubMed ID: 32043190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An in vivo gene amplification system for high level expression in Saccharomyces cerevisiae.
    Peng B; Esquirol L; Lu Z; Shen Q; Cheah LC; Howard CB; Scott C; Trau M; Dumsday G; Vickers CE
    Nat Commun; 2022 May; 13(1):2895. PubMed ID: 35610221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary and Secondary Metabolic Effects of a Key Gene Deletion (Δ
    Chen Y; Wang Y; Liu M; Qu J; Yao M; Li B; Ding M; Liu H; Xiao W; Yuan Y
    Appl Environ Microbiol; 2019 Apr; 85(7):. PubMed ID: 30683746
    [No Abstract]   [Full Text] [Related]  

  • 44. A CRISPR activation and interference toolkit for industrial Saccharomyces cerevisiae strain KE6-12.
    Cámara E; Lenitz I; Nygård Y
    Sci Rep; 2020 Sep; 10(1):14605. PubMed ID: 32884066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPR/Cas system for yeast genome engineering: advances and applications.
    Stovicek V; Holkenbrink C; Borodina I
    FEMS Yeast Res; 2017 Aug; 17(5):. PubMed ID: 28505256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lycopene overproduction in Saccharomyces cerevisiae through combining pathway engineering with host engineering.
    Chen Y; Xiao W; Wang Y; Liu H; Li X; Yuan Y
    Microb Cell Fact; 2016 Jun; 15(1):113. PubMed ID: 27329233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The gal80 Deletion by CRISPR-Cas9 in Engineered Saccharomyces cerevisiae Produces Artemisinic Acid Without Galactose Induction.
    Ai L; Guo W; Chen W; Teng Y; Bai L
    Curr Microbiol; 2019 Nov; 76(11):1313-1319. PubMed ID: 31392501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Applications of CRISPR in a Microbial Cell Factory: From Genome Reconstruction to Metabolic Network Reprogramming.
    Wu Y; Liu Y; Lv X; Li J; Du G; Liu L
    ACS Synth Biol; 2020 Sep; 9(9):2228-2238. PubMed ID: 32794766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fine-tuning of xylose metabolism in genetically engineered Saccharomyces cerevisiae by scattered integration of xylose assimilation genes.
    Zuo Q; Zhao XQ; Xiong L; Liu HJ; Xu YH; Hu SY; Ma ZY; Zhu QW; Bai FW
    Biochem Biophys Res Commun; 2013 Oct; 440(2):241-4. PubMed ID: 24051089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rewiring yeast metabolism to synthesize products beyond ethanol.
    Gambacorta FV; Dietrich JJ; Yan Q; Pfleger BF
    Curr Opin Chem Biol; 2020 Dec; 59():182-192. PubMed ID: 33032255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FnCpf1: a novel and efficient genome editing tool for Saccharomyces cerevisiae.
    Swiat MA; Dashko S; den Ridder M; Wijsman M; van der Oost J; Daran JM; Daran-Lapujade P
    Nucleic Acids Res; 2017 Dec; 45(21):12585-12598. PubMed ID: 29106617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic regulation of fatty acid pools for improved production of fatty alcohols in Saccharomyces cerevisiae.
    Teixeira PG; Ferreira R; Zhou YJ; Siewers V; Nielsen J
    Microb Cell Fact; 2017 Mar; 16(1):45. PubMed ID: 28298234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic engineering of Saccharomyces cerevisiae to improve 1-hexadecanol production.
    Feng X; Lian J; Zhao H
    Metab Eng; 2015 Jan; 27():10-19. PubMed ID: 25466225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic engineering of Saccharomyces cerevisiae using the CRISPR/Cas9 system to minimize ethyl carbamate accumulation during Chinese rice wine fermentation.
    Wu D; Xie W; Li X; Cai G; Lu J; Xie G
    Appl Microbiol Biotechnol; 2020 May; 104(10):4435-4444. PubMed ID: 32215703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Engineered CRISPR/Cas9 system for multiplex genome engineering of polyploid industrial yeast strains.
    Lian J; Bao Z; Hu S; Zhao H
    Biotechnol Bioeng; 2018 Jun; 115(6):1630-1635. PubMed ID: 29460422
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Screening neutral sites for metabolic engineering of methylotrophic yeast
    Yu W; Gao J; Zhai X; Zhou YJ
    Synth Syst Biotechnol; 2021 Jun; 6(2):63-68. PubMed ID: 33869812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cloning and characterization of a panel of mitochondrial targeting sequences for compartmentalization engineering in Saccharomyces cerevisiae.
    Dong C; Shi Z; Huang L; Zhao H; Xu Z; Lian J
    Biotechnol Bioeng; 2021 Nov; 118(11):4269-4277. PubMed ID: 34273106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae.
    Jakočiūnas T; Bonde I; Herrgård M; Harrison SJ; Kristensen M; Pedersen LE; Jensen MK; Keasling JD
    Metab Eng; 2015 Mar; 28():213-222. PubMed ID: 25638686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A vector set for systematic metabolic engineering in Saccharomyces cerevisiae.
    Fang F; Salmon K; Shen MW; Aeling KA; Ito E; Irwin B; Tran UP; Hatfield GW; Da Silva NA; Sandmeyer S
    Yeast; 2011 Feb; 28(2):123-36. PubMed ID: 20936606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineering Saccharomyces cerevisiae to produce odd chain-length fatty alcohols.
    Jin Z; Wong A; Foo JL; Ng J; Cao YX; Chang MW; Yuan YJ
    Biotechnol Bioeng; 2016 Apr; 113(4):842-51. PubMed ID: 26461930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.